Skip navigation

Navigate Current Enforcement Trends and Mitigate Risks in Relationships with Payers and Specialty Pharmacies

December 5-6, 2017
  • Philadelphia, PA

In the wake of Anti-Kickback and False Claims Act enforcement actions, manufacturers must be vigilant in maintaining compliant interactions with payers, pharmacies and physicians. CBI’s Managed Markets Compliance Congress convenes leading industry experts in compliance and contracting to
examine chief concerns facing industry including, off-label
promotion risks, fraud and abuse risks in contracting, pricing for
value-based contracts, compliance issues related to patient
assistance programs and ensuring appropriate interactions with
payers and specialty pharmacies.

CLE, CCB
& CPE Credits
Available! Pending Approval

Explore Current Compliance Issues Affecting Managed Markets Activities and Strategies to Manage Risk:

  • Review current and emerging enforcement trends involving
    managed markets activities
  • Investigate the current state of value-based contracting
    arrangements and how to create an environment where
    manufacturers can ensure compliance
  • Navigate the critical compliance issues around formularies
    including, antitrust, anti-kickback, price setting and
    Medicare Part D formulary review
  • Understand potential risk areas in managed care contracts
    regarding rebate structure and compliance issues around
    pricing and reporting
  • Develop compliant solutions to mitigate risk in specialty products
  • Discuss compliance implications for the FDA Draft Guidance
    on Payor Communications
  • Identify and evaluate key areas of risk associated with
    340B contracting and GPOs
  • Examine potential risks connected to specialty pharmacy
    arrangements including — Cost sharing arrangements, data
    service agreements, copay components and privacy issues
  • Structure PAPs in accordance with the OIG guidance
    pertaining to PAP administration

ATTENDEE ACCLAIM FOR CBI’S COMPLIANCE SERIES:

Best conference I have attended.
All material was very relevant, speakers were on point, sharp and insightful.
Timing allocation was also excellent.

Senior Compliance Manager, Johnson & Johnson

Great conference with speakers who
are industry leaders. Smaller group allowed for more open dialogue and sharing of information.

Senior Analyst Compliance, Bayer Healthcare

Managed Markets Compliance Congress

Navigate Current Enforcement Trends and Mitigate Risks in Relationships with Payers and Specialty Pharmacies

In the wake of Anti-Kickback and False Claims Act enforcement actions, manufacturers must be vigilant in maintaining compliant interactions with payers, pharmacies and physicians. CBI’s Managed Markets Compliance Congress convenes leading industry experts in compliance and contracting to
examine chief concerns facing industry including, off-label
promotion risks, fraud and abuse risks in contracting, pricing for
value-based contracts, compliance issues related to patient
assistance programs and ensuring appropriate interactions with
payers and specialty pharmacies.

CLE, CCB
& CPE Credits
Available! Pending Approval

Explore Current Compliance Issues Affecting Managed Markets Activities and Strategies to Manage Risk:

  • Review current and emerging enforcement trends involving
    managed markets activities
  • Investigate the current state of value-based contracting
    arrangements and how to create an environment where
    manufacturers can ensure compliance
  • Navigate the critical compliance issues around formularies
    including, antitrust, anti-kickback, price setting and
    Medicare Part D formulary review
  • Understand potential risk areas in managed care contracts
    regarding rebate structure and compliance issues around
    pricing and reporting
  • Develop compliant solutions to mitigate risk in specialty products
  • Discuss compliance implications for the FDA Draft Guidance
    on Payor Communications
  • Identify and evaluate key areas of risk associated with
    340B contracting and GPOs
  • Examine potential risks connected to specialty pharmacy
    arrangements including — Cost sharing arrangements, data
    service agreements, copay components and privacy issues
  • Structure PAPs in accordance with the OIG guidance
    pertaining to PAP administration

ATTENDEE ACCLAIM FOR CBI’S COMPLIANCE SERIES:

Best conference I have attended.
All material was very relevant, speakers were on point, sharp and insightful.
Timing allocation was also excellent.

Senior Compliance Manager, Johnson & Johnson

Great conference with speakers who
are industry leaders. Smaller group allowed for more open dialogue and sharing of information.

Senior Analyst Compliance, Bayer Healthcare